Related references
Note: Only part of the references are listed.Impact of the Conjugation Method on the Immunogenicity of Streptococcus pneumoniae Serotype 19F Polysaccharide in Conjugate Vaccines
Jan Poolman et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
A structurally diversified linker enhances the immune response to a small carbohydrate hapten
Tomasz Lipinski et al.
GLYCOCONJUGATE JOURNAL (2011)
Comparative effects of carrier proteins on vaccine-induced immune response
Markus Knuf et al.
VACCINE (2011)
Vi-CRM197 as a new conjugate vaccine against Salmonella Typhi
F. Micoli et al.
VACCINE (2011)
Synthetic Antitumor Vaccines from Tetanus Toxoid Conjugates of MUC1 Glycopeptides with the Thomsen-Friedenreich Antigen and a Fluorine-Substituted Analogue
Anja Hoffmann-Roder et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
How Bacterial Carbohydrates Influence the Adaptive Immune System
Fikri Y. Avci et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Haemophilus influenza tybe b (Hib) vaccine and its carrier proteins
Kwang Woo Hwang
ARCHIVES OF PHARMACAL RESEARCH (2010)
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Ursula Wiedermann et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidates
Joanna Kubler-Kielb et al.
CARBOHYDRATE RESEARCH (2010)
Effects of Hapten Density on the Induced Antibody Repertoire
Qian Li et al.
CHEMBIOCHEM (2010)
Randomized Trial on the Safety, Tolerability, and Immunogenicity of MenACWY-CRM, an Investigational Quadrivalent Meningococcal Glycoconjugate Vaccine, Administered Concomitantly with a Combined Tetanus, Reduced Diphtheria, and Acellular Pertussis Vaccine in Adolescents and Young Adults
Roberto Gasparini et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers
Susanna Esposito et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Vaccines in the management of hypertension
Thong Huy Do et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: chemical strategies to prepare glycoconjugates with good carbohydrate loading
Andrew D. Cox et al.
GLYCOCONJUGATE JOURNAL (2010)
Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading
Andrew D. Cox et al.
GLYCOCONJUGATE JOURNAL (2010)
Virus-like particle based vaccines for Alzheimer disease
Bryce Chackerian
HUMAN VACCINES (2010)
Synthetic β-(1→6)-Linked N-Acetylated and Nonacetylated Oligoglucosamines Used To Produce Conjugate Vaccines for Bacterial Pathogens
Marina L. Gening et al.
INFECTION AND IMMUNITY (2010)
Carbohydrate vaccines: developing sweet solutions to sticky situations?
Rena D. Astronomo et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Can Alzheimer disease be prevented by amyloid-β immunotherapy?
Cynthia A. Lemere et al.
NATURE REVIEWS NEUROLOGY (2010)
Production of glycoprotein vaccines in Escherichia coli
Julian Ihssen et al.
MICROBIAL CELL FACTORIES (2010)
Immunization Therapy for Alzheimer Disease: A Comprehensive Review of Active Immunization Strategies
Takeshi Tabira
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate
Anna Kabanova et al.
VACCINE (2010)
Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age
Scott A. Halperin et al.
VACCINE (2010)
Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2-10 years of age
S. Black et al.
VACCINE (2010)
Overview of the development and current use of CRM197 conjugate vaccines for pediatric use
Henry R. Shinefield
VACCINE (2010)
Glycoconjugate vaccines and immune interference: A review
Ron Dagan et al.
VACCINE (2010)
Beta-glucan-CRM197 conjugates as candidates antifungal vaccines
Carla Bromuro et al.
VACCINE (2010)
Bioanalysis of meningococcal vaccines
Neil Ravenscroft et al.
BIOANALYSIS (2010)
Thiyl Glycosylation of Olefinic Proteins: S-Linked Glycoconjugate Synthesis
Nicola Floyd et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
A Synthetic Vaccine Consisting of a Tumor-Associated Sialyl-T-N-MUC1 Tandem-Repeat Glycopeptide and Tetanus Toxoid: Induction of a Strong and Highly Selective Immune Response
Anton Kaiser et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Immunotherapy for cancer: synthetic carbohydrate-based vaccines
Therese Buskas et al.
CHEMICAL COMMUNICATIONS (2009)
Immunogenicity of a Reduced Schedule of Meningococcal Group C Conjugate Vaccine Given Concomitantly with the Prevenar and Pediacel Vaccines in Healthy Infants in the United Kingdom
Jo Southern et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents
Lisa A. Jackson et al.
CLINICAL INFECTIOUS DISEASES (2009)
Pneumococcal conjugated vaccine: PHiD-CV
Ener Cagri Dinleyici et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience
Jianglong Zhu et al.
EXPERT REVIEW OF VACCINES (2009)
Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy
David Pace
EXPERT REVIEW OF VACCINES (2009)
Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine
Ener Cagri Dinleyici et al.
EXPERT REVIEW OF VACCINES (2009)
10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix™
Roman Prymula et al.
EXPERT REVIEW OF VACCINES (2009)
Vaccines against nicotine
Erich H. Cerny et al.
HUMAN VACCINES (2009)
Anti-drug vaccines to treat substance abuse
Berma M. Kinsey et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Shigella flexneri 2a Infection
Armelle Phalipon et al.
JOURNAL OF IMMUNOLOGY (2009)
From Synthesis to Biologics: Preclinical Data on a Chemistry Derived Anticancer Vaccine
Jianglong Zhu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)
Markus Knuf et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Immunopharmacotherapy: Vaccination strategies as a treatment for drug abuse and dependence
Amira Y. Moreno et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates
John B. Robbins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM197 conjugate vaccine co-localizes with MHC II on the antigen processing cell surface
Zengzu Lai et al.
VACCINE (2009)
The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies
Antonio Nakouzi et al.
VACCINE (2009)
The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants
Eva Maria Poellabauer et al.
VACCINE (2009)
Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages
Michael Broeker et al.
VACCINE (2009)
Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years
Lars Ostergaard et al.
VACCINE (2009)
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Automated oligosaccharide synthesis
Peter H. Seeberger
CHEMICAL SOCIETY REVIEWS (2008)
Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine
Olivier Renaudet et al.
CHEMMEDCHEM (2008)
Reduction of Human Melanoma Tumor Growth in Severe Combined Immunodeficient Mice by Passive Transfer of Antibodies Induced by a High Molecular Weight Melanoma-Associated Antigen Mimotope Vaccine
Stefan Wagner et al.
CLINICAL CANCER RESEARCH (2008)
Protein D of Haemophilus influenzae:: A protective nontypeable H-influenzae antigen and a carrier for pneumococcal conjugate vaccines
Arne Forsgren et al.
CLINICAL INFECTIOUS DISEASES (2008)
Recent developments in synthetic oligosaccharide-based bacterial vaccines
Vince Pozsgay
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14
Dodi Safari et al.
INFECTION AND IMMUNITY (2008)
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants - A randomized controlled trial
Matthew D. Snape et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Molecular origins of cancer - Cancer immunology
Olivera J. Finn
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Toward solution-phase automated iterative synthesis: fluorous-tag assisted solution-phase synthesis of linear and branched mannose oligomers
Firoz A. Jaipuri et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
Synthetic glycopeptide vaccines combining β-mannan and peptide epitopes induce protection against candidiasis
Hong Xin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases
Angela Bardotti et al.
VACCINE (2008)
A clinical trial examining the effect of increased total CRM197 carrier protein dose on the antibody response to Haemophilus influenzae type b CRM197 conjugate vaccine
Vytautas Usonis et al.
VACCINE (2008)
Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide
Seshu K. Gudlavalleti et al.
VACCINE (2007)
Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice
Stefan Wagner et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Robust immune responses elicited by a fully synthetic three-component vaccine
Sampat Ingale et al.
NATURE CHEMICAL BIOLOGY (2007)
Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation
Peter C. Fusco et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Synthetic vaccines of tumor-associated glycopeptide antigens by immune-compatible thioether linkage to bovine serum albumin
Sven Wittrock et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
A potentially valuable advance in the synthesis of carbohydrate-based anticancer vaccines through extended cycloaddition chemistry
Qian Wan et al.
JOURNAL OF ORGANIC CHEMISTRY (2006)
Combination conjugate vaccines
Naor Bar-Zeev et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Biosynthesis of the N-linked glycan in Campylobacter jejuni and addition onto protein through Block transfer
J Kelly et al.
JOURNAL OF BACTERIOLOGY (2006)
Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: Lessons from mice, monkeys, and humans
CA Lemere et al.
REJUVENATION RESEARCH (2006)
Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance
AL Sorensen et al.
GLYCOBIOLOGY (2006)
Immunological memory - The role of B cells in long-term protection against invasive bacterial pathogens
DF Kelly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies
AB Riemer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Synthesis of structures corresponding to the capsular polysaccharide of Neisseria meningitidis group A
R Slättegard et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2005)
Combined conjugate vaccines: Enhanced immunogenicity with the N19 polyepitope as a carrier protein
K Baraldo et al.
INFECTION AND IMMUNITY (2005)
NMR assays for carbohydrate-based vaccines
C Jones
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2005)
Vaccines based on the cell surface carbohydrates of pathogenic bacteria
C Jones
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2005)
Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli
MF Feldman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers
J Bruge et al.
VACCINE (2004)
Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas
YF Xu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin
LM Krug et al.
CLINICAL CANCER RESEARCH (2004)
Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin
LM Krug et al.
CLINICAL CANCER RESEARCH (2004)
A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b
V Verez-Bencomo et al.
SCIENCE (2004)
Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants
M Rennels et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
A glycopeptide in complex with MHC class I uses the GaINAc residue as an anchor
V Apostolopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cancer vaccines: Between the idea and the reality
OJ Finn
NATURE REVIEWS IMMUNOLOGY (2003)
A new strategy for improved nicotine vaccines using conformationally constrained haptens
MM Meijler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Carbohydrate-protein conjugate vaccines
G Ada et al.
CLINICAL MICROBIOLOGY AND INFECTION (2003)
Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria
L Schofield et al.
NATURE (2002)
Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses
DS Berry et al.
INFECTION AND IMMUNITY (2002)
Meningococcal serogroup C conjugate vaccine
R Lakshman et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2002)
Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM197 conjugates induce protection against Streptococcus pneumoniae type 3 in mice
B Benaissa-Trouw et al.
INFECTION AND IMMUNITY (2001)
Toward optimized carbohydrate-based anticancer vaccines:: Epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewisy conjugates in mice
V Kudryashov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice
WTM Jansen et al.
INFECTION AND IMMUNITY (2001)
O-glycosylation of the mucin type
FA Hanisch
BIOLOGICAL CHEMISTRY (2001)
The chemistry and immunochemistry of blood group A, B, H, and Lewis antigens: Past, present and future
KO Lloyd
GLYCOCONJUGATE JOURNAL (2000)
Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses
J Alexander et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
